CV Sciences, Inc. (CVSI)

Market Cap	6.12M +22.0%
Revenue (ttm)	13.38M -12.6%
Net Income	-1.49M
EPS	-0.01
Shares Out	197.33M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111,979
Average Volume	582,707
Open	0.0300
Previous Close	0.0300
Day's Range	0.0290 - 0.0300
52-Week Range	0.0230 - 0.1000
Beta	0.45
RSI	48.37
Earnings Date	May 14, 2026

About CV Sciences

CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet brand names in various health care sectors, including nutraceutical, beauty care, specialty foods, and pet products. It sells its products through its websites, internet sales, elect dis...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2010
• Employees: 44
• Stock Exchange: OTCMKTS
• Ticker Symbol: CVSI

Financial Performance

In 2025, CV Sciences's revenue was $13.79 million, a decrease of -12.20% compared to the previous year's $15.71 million. Losses were -$958,000, -59.98% less than in 2024.